⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 2, 2021Scandinavian Journal of Rheumatology

Increased salivary syndecan-1 level is associated with salivary gland function and inflammation in patients with Sjögren’s syndrome

N. Y. Lee NR Kim JW Kang G Kim M-S Han JA Jang Dong Kuk Ahn J-H Jeong M-H Han EJ Nam

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Salivary and plasma SDC-1 levels may constitute potential biomarkers for salivary gland function and disease activity, respectively, in SS.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2021) studied this question.

synapsesocial.com/papers/69da67a23e67f8d1386844ad https://doi.org/10.1080/03009742.2021.1923162

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Syndecan-1 Plays a Role in the Pathogenesis of Sjögren’s Disease by Inducing B-Cell Chemotaxis through CXCL13–Heparan Sulfate Interaction2024 · 2 citations
2Diagnostic significance of salivary and glandular siglec-5 in Sjögren disease and non-Sjögren siccaOriginal Research · 2026 · 1 citations
3Elevated Serum Levels of Syndecan-1 Are Associated with Renal Involvement in Patients with Systemic Lupus ErythematosusOriginal Research · 2014 · 52 citations
4Distinct molecular profile in Sjögren’s syndrome is associated with disease activity and clinical manifestationsOriginal Research · 2026 · 1 citations
5Salivary Galectin-9 Levels in Primary Sjögren’s Disease: An Observational Cross-Sectional Case–Control StudyCross-Sectional Study · 2026